Pharmacokinetics, pharmacodynamics and safety of QGE031 (ligelizumab), a novel high-affinity anti-IgE antibody, in atopic subjects.

Autor: Arm, J. P.1, Bottoli, I.2, Skerjanec, A.3, Floch, D.3, Groenewegen, A.4, Maahs, S.5, Owen, C. E.6, Jones, I.7, Lowe, P. J.8
Zdroj: Clinical & Experimental Allergy. Nov2014, Vol. 44 Issue 11, p1371-1385. 15p. 1 Diagram, 3 Charts, 4 Graphs.
Databáze: Academic Search Ultimate